News

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Novo Nordisk’s weight loss drug, Wegovy, is experiencing a surge in new prescriptions following a US ban on its copycat ...
Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...
GLP-1s (glucagon-like peptide-1 receptor agonists), like Wegovy, Ozempic, or generic liraglutide, have helped you reach your ...
A U.S. ban on copycat versions of Novo Nordisk's Wegovy has begun to lift use of the weight loss drug, but the company will ...
As of 2024, Brazil's Semaglutide market was estimated at $581 million. The global market size for the GLP-1 (glucagon-like ...
Pharmacies have warned that the demand for weight loss medication risks going far beyond what is clinically deliverable 🚨 ...
A new analysis of 11 global studies shows that people tend to regain lost weight after stopping anti-obesity medications like ...
NPA chairman Olivier Picard said ‘many more people are interested in getting weight loss jabs than would actually be suitable ...
While treatments like Ozempic, Mounjaro and Wegovy can provide a helping hand, there’s no magic bullet when it comes to ...
The booming demand for weight loss jabs may be unsustainable, pharmacists warn. Many more patients are interested in using ...
FAT jabs do often sound like a magical quick fix to overeating and demanding hunger pangs.  But the drugs can leave some ...